ALLMedicine™ Iron-binding Capacity Center
Research & Reviews 125 results
American Journal of Hematology; Koury MJ, Agarwal R et. al.
Jun 26th, 2022 - Patients with chronic kidney disease develop anemia largely because of inappropriately low erythropoietin production and insufficient iron available to erythroid precursors. In four phase 3, randomized, open-label, clinical trials in dialysis-depe...
https://doi.org/10.1007/s10157-022-02225-w 10.1681/ASN.2011111078 10.1053/j.ajkd.2014.08.001 10.4239/wjd.v5.i5.651 10.1185/030079904X2763 10.1371/journal.pone.0236132 10.1681/ASN.2010010116 10.1111/j.1440-1797.2007.00810.x 10.1007/s10157-020-01969-7 10.1111/1744-9987.12712 10.1681/ASN.V103610 10.1111/j.1523-1755.2004.00863.x 10.1016/j.ekir.2021.04.003 10.1093/ndt/gfab057 10.1016/j.ekir.2020.11.034 10.1681/ASN.2020081150 10.1093/ndt/gfab191 10.2337/diacare.26.4.1164 10.1016/j.ymgmr.2020.100661 10.23937/2377-3634/1410128 10.3390/ijms21197153 10.1182/blood-2003-03-0672 10.1159/000519043 10.1056/NEJMoa1901713 10.1056/NEJMoa1813599 10.1016/j.kint.2015.10.002 10.1681/ASN.2019060623 10.4161/cc.7.1.5145 10.1038/ki.1996.487 10.2215/CJN.06890615 10.1093/ndt/gfab191 10.1016/j.cmet.2006.02.002 10.1074/jbc.M704976200 10.1074/jbc.M117.788562 10.1371/journal.pone.0173843 10.1038/ki.2009.21 10.1186/s12882-018-1119-7
Clinical and Experimental Nephrology; Akizawa T, Tanaka-Amino K et. al.
Apr 26th, 2022 - Roxadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor for treating anemia of chronic kidney disease (CKD). This post hoc analysis of a Japanese, open-label, partially randomized, phase 3 study in patients with non-dialysis-de...
https://doi.org/10.1007/s00277-022-04835-6 10.1016/S0140-6736(17)32154-2 10.1016/j.beha.2004.08.022 10.4314/ajtcam.v11i2.19 10.1016/S2352-3026(17)30182-5 10.1136/gutjnl-2021-325210 10.1182/blood-2015-05-642223 10.1111/imj.14766 10.1172/JCI200420945 10.1182/blood-2007-04-087593 10.3945/ajcn.2009.28129 10.1007/s00277-019-03871-z 10.1093/ajcn/62.1.117
Annals of Hematology; Kaynar LA, Gökçen S et. al.
Apr 24th, 2022 - Iron-deficiency anemia (IDA) is accepted as the most common cause of anemia in the world. The main goals of iron replacement therapy are to normalize the hemoglobin level and to replace iron stores. Current guidelines for treating iron deficiency ...
The Journal of International Medical Research; Wu Y, Huang B et. al.
Apr 14th, 2022 - To compare the all-cause mortality of aged and younger patients undergoing maintenance hemodialysis (MHD) over the long or short term, and to identify independent risk factors. We performed a retrospective cohort study using the medical records of...
PloS One; Abdelazeem B, Shehata J et. al.
Apr 2nd, 2022 - Roxadustat (ROX) is a new medication for anemia as a complication of chronic kidney disease (CKD). Our meta-analysis aims to evaluate the efficacy and safety of ROX, especially on the cardiovascular risks, for anemia in NDD-CKD patients. Electroni...
Clinicaltrials.gov 4 results
Mar 29th, 2022 - FOLFOX, the first-line regimen based on 5-FU and oxaliplatin, is adjuvant chemotherapy for pathologic stage II/III colorectal cancer patients. Among various side effects of FOLFOX, chemotherapy-induced anemia occurs in about 30% of patients with F...
Oct 5th, 2020 - POD-1 : Researchers will meet patients scheduled for surgery and explain the study. (enroll) the operation date : The patient will sign the consent form. Researchers will collect the blood sample from the patient for testing hepcidin during the op...
Sep 24th, 2020 - Women who were admitted and treated for HMB were asked to participate in this comparative study. Women were eligible for entry if they had self-described heavy menstrual bleeding, had a regular cycle, had completed their family and were 40-50 year...
May 9th, 2017 - Crohn's disease (CD) and ulcerative colitis (UC) are chronic gastrointestinal diseases characterized by relapsing and remitting inflammation of the intestines . Anemia may often complicate the course of inflammatory bowel disease (IBD) . A recent ...
News 12 results
Joshua Cash, MD, Ashley Skinner et. al.
Mar 1st, 2020 - Porphyria cutanea tarda (PCT) is the most common type of porphyria. The accumulation of porphyrin in various organ systems results from a deficiency of uroporphyrinogen decarboxylase (UROD).
Aug 28th, 2019 - Combination quercetin and desferrioxamine could decrease iron overload in patients with transfusion-dependent beta-thalassemia major, according to a randomized clinical study. Over the course of treatment, quercetin was well tolerated and no major.
Jun 15th, 2017 - Ferrous sulfate drops A trial comparing ferrous sulfate with iron polysaccharide complex to treat infants and young children with nutritional iron-deficiency anemia (IDA) has shown ferrous sulfate to be more effective at raising hemoglobin levels.
Jun 13th, 2017 - Once daily ferrous sulfate was superior to iron polysaccharide when given to young kids with nutritional iron deficiency anemia, a small trial found. Researchers writing in the Journal of the American Medical Association found that children ages 9...
Sep 25th, 2013 - Clinical Presentation The patient was a 33-year-old, well-conditioned male athlete who presented to a referring hospital with a 4-day history of fatigue, lethargy, fever, chills, jaundice, dark urine, and abdominal pain. His medical history includ...